Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 7, Number 3—June 2001
Research

Molecular Epidemiology of Serogroup A Meningitis in Moscow, 1969 to 1997

Mark Achtman*Comments to Author , Arie van der Ende†, Peixuan Zhu*, Irina S. Koroleva‡, Barica Kusecek*, Giovanna Morelli*, Ilse G.A. Schuurman†, Norbert Brieske*, Kerstin Zurth*, Natalya N. Kostyukova§, and Alexander E. Platonov‡
Author affiliations: *Max-Planck Institut für Molekulare Genetik, Berlin, Germany; †Academic Medical Center, Amsterdam, the Netherlands; ‡Central Research Institute of Epidemiology, Moscow, Russia; §N.F. Gamaleya Institute of Epidemiology and Microbiology, Moscow, Russia

Main Article

Figure 2

UPGMA tree of band differences between random amplified polymorphic DNA (RAPD) patterns from 103 serogroup A strains from Moscow. RAPD tests were performed with primers 1254, 1281, NM03, and NM04 as described (7), generating four patterns for each strain. The combination of the differences between these patterns was used to generate a UPGMA tree with the program GelCompar (Applied Maths, Kortrijk, Belgium), as described (7). Subgroup designations are indicated within the tree. The strain designa

Figure 2. . UPGMA tree of band differences between random amplified polymorphic DNA (RAPD) patterns from 103 serogroup A strains from Moscow. RAPD tests were performed with primers 1254, 1281, NM03, and NM04 as described (7), generating four patterns for each strain. The combination of the differences between these patterns was used to generate a UPGMA tree with the program GelCompar (Applied Maths, Kortrijk, Belgium), as described (7). Subgroup designations are indicated within the tree. The strain designations and the sequence type (ST) assignments from MLST analysis are shown at the right. For subgroup III bacteria, dark gray rectangles indicate pgm3 and light gray rectangles indicate pgm19. Strain Z4714 is indicated as belonging to subgroup IV because RAPD does not distinguish between subgroups IV-1 and IV-2.

Main Article

References
  1. Peltola  H. Meningococcal disease: still with us. Rev Infect Dis. 1983;5:71–91. DOIPubMedGoogle Scholar
  2. Crowe  BA, Wall  RA, Kusecek  B, Neumann  B, Olyhoek  T, Abdillahi  H, Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in the Gambia, West Africa. J Infect Dis. 1989;159:686–700. DOIPubMedGoogle Scholar
  3. Achtman  M. Molecular epidemiology of epidemic bacterial meningitis. Rev Med Microbiol. 1990;1:29–38.
  4. Achtman  M. Global epidemiology of meningococcal disease. In: Cartwright K, editor. Meningococcal disease. Chichester, England: John Wiley & Sons, Ltd; 1995:159-75.
  5. Tikhomirov  E, Santamaria  M, Esteves  K. Meningococcal disease: public health burden and control. World Health Stat Q. 1997;50:170–6.PubMedGoogle Scholar
  6. Maiden  MCJ, Bygraves  JA, Feil  E, Morelli  G, Russell  JE, Urwin  R, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998;95:3140–5. DOIPubMedGoogle Scholar
  7. Bart  A, Schuurman  IGA, Achtman  M, Caugant  DA, Dankert  J, van der Ende  A. Random amplified polymorphic DNA (RAPD) genotyping of serogroup A meningococci yields similar results to multilocus enzyme electrophoresis (MEE) and reveals new genotypes. J Clin Microbiol. 1998;36:1746–9.PubMedGoogle Scholar
  8. Wang  J-F, Caugant  DA, Li  X, Hu  X, Poolman  JT, Crowe  BA, Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in China. Infect Immun. 1992;60:5267–82.PubMedGoogle Scholar
  9. Hjetland  R, Caugant  DA, Hofstad  T, Frøholm  LO, Selander  RK, Serogroup  A. Neisseria meningitidis of clone III-1 in western Norway, 1969-73. Scand J Infect Dis. 1990;22:241–2. DOIPubMedGoogle Scholar
  10. Mäkelä  PH, Peltola  H, Käyhty  H, Jousimies  H, Pettay  O, Ruoslahti  E, Polysaccharide vaccines to group A Neisseria meningitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis. 1977;136:43–50. DOIPubMedGoogle Scholar
  11. Achtman  M, Kusecek  B, Morelli  G, Eickmann  K, Wang  J, Crowe  B, A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. J Infect Dis. 1992;165:53–68. DOIPubMedGoogle Scholar
  12. Moore  PS, Reeves  MW, Schwartz  B, Gellin  BG, Broome  CV. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet. 1989;ii:260–3. DOIPubMedGoogle Scholar
  13. Jones  DM, Sutcliffe  EM. Group A meningococcal disease in England associated with the Haj. J Infect. 1990;21:21–5. DOIPubMedGoogle Scholar
  14. Riou  JY, Caugant  DA, Selander  RK, Poolman  JT, Guibourdenche  M, Collatz  E. Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern. Eur J Clin Microbiol Infect Dis. 1991;10:405–9. DOIPubMedGoogle Scholar
  15. Maiden  MCJ, Malorny  B, Achtman  M. A global gene pool in the neisseriae. Mol Microbiol. 1996;21:1297–8. DOIPubMedGoogle Scholar
  16. Linz  B, Schenker  M, Zhu  P, Achtman  M. Frequent interspecific genetic exchange between commensal neisseriae and Neisseria meningitidis. Mol Microbiol. 2000;36:1049–58. DOIPubMedGoogle Scholar
  17. Morelli  G, Malorny  B, Müller  K, Seiler  A, Wang  J, del Valle  J, Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread. Mol Microbiol. 1997;25:1047–64. DOIPubMedGoogle Scholar
  18. Bolshakov  KN. Epidemiological and geographical aspects of meningococcal infection [dissertation]. Moscow: Moscow Univ.; 1973.
  19. Kostyukova  NN, Mironova  TK, Leschinskaya  EV. Microbiological characteristics of meningococcus infection in Moscow during a periodic rise in morbidity (1968-1971). Zh Mikrobiol Epidemiol Immunobiol. 1974;5:29–32.
  20. Demina  AA, Martinov  JV. An analysis of the epidemic cycle of meningococcal infection in Russia (1969-1993). Zh Mikrobiol Epidemiol Immunobiol. 1996;4:57–61.PubMedGoogle Scholar
  21. Sarkari  J, Pandit  N, Moxon  ER, Achtman  M. Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine. Mol Microbiol. 1994;13:207–17. DOIPubMedGoogle Scholar
  22. Zhu  P, Morelli  G, Achtman  M. The opcA and opcB regions in Neisseria: genes, pseudogenes, deletions, insertion elements and DNA islands. Mol Microbiol. 1999;33:635–50. DOIPubMedGoogle Scholar
  23. Zhu  P, van der Ende  A, Falush  D, Beieske  N, Morelli  G, Linz  B, Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci U S A. 2001. In press.PubMedGoogle Scholar
  24. Kwara  A, Adegbola  RA, Corrah  PT, Weber  M, Achtman  M, Morelli  G, Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health. 1998;3:742–6. DOIPubMedGoogle Scholar
  25. Vogel  U, Morelli  G, Zurth  K, Claus  H, Kriener  E, Achtman  M, Necessity of molecular techniques to distinguish between Neisseria meningitidis isolated from meningococcal disease and from their healthy contacts. J Clin Microbiol. 1998;36:2465–70.PubMedGoogle Scholar
  26. Van Embden  JDA, Cave  MD, Crawford  JT, Dale  JW, Eisenach  KD, Gicquel  B, Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendation for a standardized methodology. J Clin Microbiol. 1993;31:406–9.PubMedGoogle Scholar
  27. Keim  P, Kalif  A, Schupp  J, Hill  K, Travis  SE, Richmond  K, Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers. J Bacteriol. 1997;179:818–24.PubMedGoogle Scholar
  28. Keim  P, Klevytska  AM, Price  LB, Schupp  JM, Zinser  G, Smith  KL, Molecular diversity in Bacillus anthracis. J Appl Microbiol. 1999;87:215–7. DOIPubMedGoogle Scholar
  29. Vieusseux  M. Mémoire sur le maladie qui a régné à Genève au printemps de 1805. J Med Chirurg Pharm. 1806;11:163–82.
  30. Swartley  JS, Marfin  AA, Edupuganti  S, Liu  LJ, Cieslak  P, Perkins  B, Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A. 1997;94:271–6. DOIPubMedGoogle Scholar
  31. Parkhill  J, Achtman  M, James  KD, Bentley  SD, Churcher  C, Klee  SR, Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature. 2000;404:502–6. DOIPubMedGoogle Scholar
  32. Scholten  RJPM, Bijlmer  HA, Poolman  JT, Kuipers  B, Caugant  DA, van Alphen  L, Meningococcal disease in the Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. J Infect Dis. 1993;16:237–46. DOIPubMedGoogle Scholar
  33. Caugant  DA, Høiby  EA, Magnus  P, Scheel  O, Hoel  T, Bjune  G, Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 1994;32:323–30.PubMedGoogle Scholar

Main Article

Page created: April 26, 2012
Page updated: April 26, 2012
Page reviewed: April 26, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external